BIBW 2992 After Administration of Docetaxel in Patients With Advanced Solid Tumors

NCT02171676 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms

Interventions

DRUG: Docetaxel
DRUG: BIBW 2992

Sponsor

Boehringer Ingelheim